Boston Scientific Expects Results
Boston Scientific Corporation announced the schedule of the Company's major events and press announcements at the European Society of Cardiology/World Congress of Cardiology 2006, which runs from September 2 to 6 in Barcelona, Spain. The Company plans to announce four-year results from the TAXUS II clinical trial. The data are expected to build on the strong body of clinical evidence supporting the continued long-term safety profile of the TAXUS Express2(TM) Paclitaxel-Eluting Stent System.
Boston Scientific will also announce six-month data from the initial phase of the OLYMPIA registry, designed to study real-world outcomes of its TAXUS Liberte(TM) Paclitaxel-Eluting Stent System. The Company anticipates the data will further reinforce the safety and efficacy of its second-generation drug- eluting stent system. In addition, the Company will host a symposium focusing on the treatment of challenging patients with drug-eluting stents, as well as separate symposia highlighting therapies in cardiac rhythm management and carotid artery disease.
Schedule of events:
Tuesday, September 5 (all times are Barcelona time)
- OLYMPIA Phase I six-month data - results from Phase I of the global OLYMPIA registry will be announced.
- Satellite Symposium on cardiac rhythm management entitled "Treatment of patients with advanced heart failure: device therapy when medications are not enough".
- Symposium on drug-eluting stents entitled "Drug-eluting stents in challenging patients,".
Wednesday, September 6:
- TAXUS II long term data - four-year clinical follow-up results from the TAXUS II clinical trial will be presented.
Boston Scientific will present its latest innovations at booth J500 in the Exhibition hall. In addition, the Company will participate in the WCC public awareness initiative, "For Your Heart's Sake 2006". The event will take place September 1-2 on the Placa Catalunya in Barcelona, and is designed to educate the general public on woman's health and cardiovascular diseases through a variety of risk assessment stations and interactive demonstrations intended to promote heart healthy lifestyles. Boston Scientific will also have cardiologists available on site to answer questions.
write your comments about the article :: © 2006 Exhibition News :: home page